MR imaging of myocardial perfusion and viability

Magnetic Resonance Imaging Clinics of North America

Volumn 11, Issue 1, 2003, Pages 49-66

  Wagner, Anja ^a,b   Mahrholdt, Heiko ^a,b   Sechtem, Udo ^b   Kim, Raymond J ^a   Judd, Robert M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; GADODIAMIDE; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOTETRIOLE; UNCLASSIFIED DRUG;

CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG HALF LIFE; EXERCISE TEST; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART STIMULATION; HEART VENTRICLE WALL; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; TECHNIQUE;

EID: 0037301847     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1064-9689(02)00048-X     Document Type: Review

References (107)

1. American Heart Association. Heart and stroke statistical update. Dallas (TX): American Heart Association, 2000.
2. Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 1982;65(5):928-35.
3. Berman DS, Kiat H, Van Train KF, et al. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990;66(13):72E-9E.
4. Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67(16):1303-10.
5. McKinnon GC. Ultrafast interleaved gradient-echo-planar imaging on a standard scanner. Magn Reson Med 1993;30(5):609-16.
6. Edelman RR, Wielopolski P, Schmitt F. Echoplanar MR imaging. Radiology 1994;192(3):600-12.
7. Schwitter J, Debatin JF, von Schulthess GK, et al. Normal myocardial perfusion assessed with multishot echo-planar imaging. Magn Reson Med 1997;37(1):140-7.
8. Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 2001;219(1):264-9.
9. Jakob PM, Griswold MA, Edelman RR, et al. Accelerated cardiac imaging using the SMASH technique. J Cardiovasc Magn Reson 1999;1(2):153-7.
10. Weiger M, Pruessmann KP, Boesiger P. Cardiac real-time imaging using SENSE. SENSitivity encoding scheme. Magn Reson Med 2000;43(2):177-84.
11. Rehwald WG, Kim RJ, Simonetti OP, et al. Theory of high-speed MR imaging of the human heart with the selective line acquisition mode. Radiology 2001;220(2):540-7.
12. Saeed M, Wendland MF, Higgins CB. Contrast media for MR imaging of the heart. J Magn Reson Imaging 1994;4(3):269-79.
13. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, et al. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol 1991;26(11):969-74.
14. Wendland MF, Saeed M, Yu KK, et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 1994;32(3):319-29.
15. Vallee JP, Lazeyras F, Kasuboski L, et al. Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function. J Magn Reson Imaging 1999;9(2):197-203.
16. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204(2):373-84.
17. Jerosch-Herold M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Cardiovasc Imaging 1997;13(3):205-18.
18. Lauerma K, Virtanen KS, Sipila LM, et al. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96(9):2859-67.
19. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997;30(4):1086-94.
20. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41(2):267-78.
21. Eichenberger AC, Schuiki E, Kochli VD, et al. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging 1994;4(3):425-31.
22. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 1996;35(2):221-8.
23. Keijer JT, van Rossum AC, van Eenige MJ, et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 1995;130(4):893-901.
24. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101(12):1379-83.
25. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15(2):459-74.
26. Cullen JH, Horsfield MA, Reek CR, et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33(5):1386-94.
27. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993;30(3):337-46.
28. Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36(2):225-31.
29. Manning WJ, Atkinson DJ, Parker JA, Edelman RR. Assessment of intracardiac shunts with gadolinium-enhanced ultrafast MR imaging. Radiology 1992;184(2):357-61.
30. Kety SS. Measurement of local contribution within the brain by means of inert, diffusible tracers; examination of the theory, assumptions and possible sources of error. Acta Neurol Scand Suppl 1965;14:20-3.
31. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991;20(2):299-305.
32. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23(2):239-53.
33. Fritz-Hansen T, Rostrup E, Ring PB, et al. Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. Magn Reson Imaging 1998;16(8):893-9.
34. Harris PA, Lorenz CH, Holburn GE, et al. Regional measurement of the Gd-DTPA tissue partition coefficient in canine myocardium. Magn Reson Med 1997;38(4):541-5.
35. Larsson HB, Fritz-Hansen T, Rostrup E, et al. Myocardial perfusion modeling using MRI. Magn Reson Med 1996;35(5):716-26.
36. Kraitchman DL, Wilke N, Hexeberg E, et al. Myocardial perfusion and function in dogs with moderate coronary stenosis. Magn Reson Med 1996;35(5):771-80.
37. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29(4):485-97.
38. Miller DD, Holmvang G, Gill JB, et al. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia. Magn Reson Med 1989;10(2):246-55.
39. Schaefer S, Lange RA, Gutekunst DP, et al. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Invest Radiol 1991;26(6):551-6.
40. Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 1990;174(3 Pt 1):757-62.
41. Hartnell G, Cerel A, Kamalesh M, et al. Detection of myocardial ischemia: value of combined myocardial perfusion and cineangiographic MR imaging. AJR Am J Roentgenol 1994;163(5):1061-7.
42. Klein MA, Collier BD, Hellman RS, Bamrah VS. Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo-fast low-angle shot MR images. AJR Am J Roentgenol 1993;161(2):257-63.
43. Manning WJ, Atkinson DJ, Grossman W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991;18(4):959-65.
44. Walsh EG, Doyle M, Lawson MA, et al. Multislice first-pass myocardial perfusion imaging on a conventional clinical scanner. Magn Reson Med 1995;34(1):39-47.
45. Nagel E, Al-Saadi N, Paetsch I. Magnetic resonance myocardial perfusion reserve for the detection of coronary artery disease in an unselected patient population. Presented at the meeting of the American Heart Association. Atlanta, Georgia, 1999.
46. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79(4):825-35.
47. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31(12):1899-905.
48. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31(3):534-40.
49. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 1994;35(4):693-8.
50. Simone GL, Mullani NA, Page DA, et al. Utilization statistics and diagnostic accuracy of a nonhospital-based positron emission tomography center for the detection of coronary artery disease using rubidium-82. Am J Physiol Imaging 1992;7(3-4):203-9.
51. Williams BR, Mullani NA, Jansen DE, et al. A retrospective study of the diagnostic accuracy of a community hospital-based PET center for the detection of coronary artery disease using rubidium-82. J Nucl Med 1994;35(10):1586-92.
52. Al-Saadi N, Nagel E, Gross M, et al. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol 2000;36:1557-64.
53. Wilke N, Jerosch-Herold M. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging. Cardiol Clin 1998;16(2):227-46.
54. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1(10):1085-9.
55. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100(18):1865-71.
56. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59(3):421-30.
57. Harris PJ, Harrell FE, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation 1979;60(6):1259-69.
58. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982;66(3):562-8.
59. Kaul S. Assessing the myocardium after attempted reperfusion: should we bother? Circulation 1998;98(7):625-7.
60. Zabel M, Hohnloser SH, Koster W, et al. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87(5):1542-50.
61. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993;88(2):750-63.
62. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101(5):593-600.
63. Mallory GK, White PD, Salcedo-Galger J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases. Am Heart J 1939;18:647-71.
64. Dubnow MH, Burchell HB, Titus JL. Postinfarction ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J 1965;70(6):753-60.
65. Perrone-Filardi P, Bacharach SL, Dilsizian V, et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1992;20(1):161-8.
66. Lawson MA, Johnson LL, Coghlan L, et al. Correlation of thallium uptake with left ventricular wall thickness by cine magnetic resonance imaging in patients with acute and healed myocardial infarcts. Am J Cardiol 1997;80(4):434-41.
67. Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol 1986;7(2):349-54.
68. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93(2):223-8.
69. Sandstede JJ, Bertsch G, Beer M, et al. Detection of myocardial viability by low-dose dobutamine Cine MR imaging. Magn Reson Imaging 1999;17(10):1437-43.
70. Heusch G, Schulz R. Hibernating myocardium: a review. J Mol Cell Cardiol 1996;28(12):2359-72.
71. Cigarroa CG, deFilippi CR, Brickner ME, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88(2):430-6.
72. Sechtem U, Baer FM, Voth E, et al. Assessment of viability by MR-techniques. Dordrecht: Kluwer; 1996. p. 211-36.
73. Sechtem U, Sommerhoff BA, Markiewicz W, et al. Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. Am J Cardiol 1987;59(1):145-51.
74. Stollfuss JC, Haas F, Matsunari I, et al. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99mTc-tetrofosmin single-photon emission tomography and magnetic resonance imaging. Eur J Nucl Med 1998;25(5):522-30.
75. Dendale PA, Franken PR, Waldman GJ, et al. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 1995;130(1):134-40.
76. Dendale P, Franken PR, Block P, et al. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998;135(5 Pt 1):875-80.
77. Baer FM, Smolarz K, Jungehulsing M, et al. Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT. Am Heart J 1992;123(3):636-45.
78. Baer FM, Voth E, LaRosee K, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996;78(4):415-9.
79. Fedele F, Montesano T, Ferro-Luzzi M, et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging. Am Heart J 1994;128(3):484-9.
80. Pereira RS, Prato FS, Wisenberg G, et al. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36(5):684-93.
81. Pereira RS, Prato FS, Sykes J, et al. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med 1999;42(1):60-80.
82. McNamara MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158(3):765-9.
83. Barkhausen J, Ebert W, Debatin JF, et al. Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. J Am Coll Cardiol 2002;39(8):1392-8.
84. Jennings RB, Schaper J, Hill ML, et al. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56(2):262-78.
85. Fozzard HA, Haber E, Jennings RB. Myocardial ischemia, hypoxia and infarction. In: Fozzard HA et al, editors. The heart and cardiovascular system. 2nd edition. New York: Raven; 1992. p. 1875-973.
86. Whalen DA, Hamilton DG, Ganote CE, et al. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol 1974;74(3):381-97.
87. Kim RJ, Fieno DS, Parrish TB, et al. Relationhip of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002.
88. Koenig SH, Spiller M, Brown RD III, et al. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn Reson Med 1986;3(5):791-5.
89. Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142(3):619-24.
90. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36(6):1985-91.
91. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, in press.
92. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357(9249):21-8.
93. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105(2):162-7.
94. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-53.
95. Edelman RR, Wallner B, Singer A, et al. Segmented turboFLASH: method for breath-hold MR imaging of the liver with flexible contrast. Radiology 1990;177(2):515-21.
96. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218(1):215-23.
97. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurements by contrast enhanced MRI. Circulation 2002;106:2322-27.
98. Van Rossum AC, Visser FC, Van Eenige MJ, et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990;65(13):845-51.
99. de Roos A, van Rossum AC, van der Wall E, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989;172(3):717-20.
100. Lima JA, Judd RM, Bazille A, et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92(5):1117-25.
101. Eichstaedt HW, Felix R, Danne O, et al. Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA. Cardiovasc Drugs Ther 1989;3(5):779-88.
102. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-mb elevation. Circulation 2001;103(23):2780-3.
103. Mahrholdt H, Wagner A, Choi K, et al. Contrast MRI detects subendocardial infarcts in regions of normal wall motion [abstract]. Circulation 2001;104(Suppl II):341.
104. Hillenbrand HB, Kim RJ, Parker MA, et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102(14):1678-83.
105. Choi K, Kim RJ, Gubernikoff G, et al. The transmural extent of acute myocardial infarction predicts long term improvement in contractile function. Circulation 2001;104(10):1101-7.
106. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90(2):735-45.
107. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96(9):2892-8.